From Casetext: Smarter Legal Research

Huckaby v. Takeda Pharm. U.S., Inc. (In re Actos® (Pioglitazone) Prods. Liab. Litig.)

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA LAFAYETTE DIVISION
Jul 7, 2015
Case No. 6:14-cv-2627 (W.D. La. Jul. 7, 2015)

Opinion

Case No. 6:14-cv-2627 MDL No. 6:11-md-2299

07-07-2015

IN RE: ACTOS® (PIOGLITAZONE) PRODUCTS LIABILITY LITIGATION This Document Applies To: Huckaby v. Takeda Pharmaceutical USA, Inc., et al


MAGISTRATE JUDGE HANNA RULING

The Court received a motion, entitled Unopposed Motion for Leave [Rec. Doc. 5655], requesting leave to register the captioned claim in the Census of Claims after the deadline given in this Court's Case Management Order Regarding Census of Claims [Rec. Doc. 5551] ("the Census Order"). The Court provided notice of the motion's filing to all parties and an opportunity to oppose it [Rec. Doc. 5664]. The sole response to the motion was notice by the Co-Lead Counsel of the Plaintiffs' Steering Committee ("PSC") that they do not oppose inclusion of the captioned case in the Census [Rec. Doc. 5679]. The Court now turns to the merits of the motion.

The motion indicates counsel received notice of the Census Order, yet inadvertently failed to register the captioned claim by the deadline given in it, in effect arguing excusable neglect. The claim was originally filed with this Court on or before May 1, 2015, and consequently would have been eligible for inclusion in the Census. The motion for leave to register after the deadline was filed within 13 days of the deadline set by this Court. Considering each of these factors, and the lack of opposition by the PSC and Defendants, the Court finds that counsel's failure to register with the Census prior to the deadline does fall within the scope of "excusable neglect" referenced in FED.R.CIV.P. 6(b)(1). The Court notes that excusable neglect is a narrow concept which this Court does not apply lightly, and this determination should not be seen as precedent for any future filings that might come after this ruling.

The Court notes, however, that counsel's motion additionally requests permission to be able to participate in the Settlement Program. This Court does not have authority to grant or deny that permission; participation in the Settlement Program is governed by the terms of the MSA. Therefore, that portion of movant's motion is DENIED.

IT IS HEREBY ORDERED counsel's Unopposed Motion for Leave [Rec. Doc. 5655] is GRANTED IN PART and DENIED IN PART. Counsel's request for leave to register the claim in the captioned case with the Census of Claims is GRANTED. Counsel's request for permission to participate in the Settlement Program is DENIED as outside this Court's purview.

THUS DONE AND SIGNED in Lafayette, Louisiana, this 7th day of July, 2015.

/s/_________

REBECCA F. DOHERTY

UNITED STATES DISTRICT JUDGE


Summaries of

Huckaby v. Takeda Pharm. U.S., Inc. (In re Actos® (Pioglitazone) Prods. Liab. Litig.)

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA LAFAYETTE DIVISION
Jul 7, 2015
Case No. 6:14-cv-2627 (W.D. La. Jul. 7, 2015)
Case details for

Huckaby v. Takeda Pharm. U.S., Inc. (In re Actos® (Pioglitazone) Prods. Liab. Litig.)

Case Details

Full title:IN RE: ACTOS® (PIOGLITAZONE) PRODUCTS LIABILITY LITIGATION This Document…

Court:UNITED STATES DISTRICT COURT WESTERN DISTRICT OF LOUISIANA LAFAYETTE DIVISION

Date published: Jul 7, 2015

Citations

Case No. 6:14-cv-2627 (W.D. La. Jul. 7, 2015)